HAMP and chronic kidney disease: Serum hepcidin levels in the darbepoetin alfa group transiently decreased with hematopoiesis but returned to baseline levels at 24 weeks, while serum hepcidin levels in the vadadustat group remained decreased after 24 weeks, even though maintained hemoglobin levels between the two groups were comparable in the NDD-CKD study [9].